Filing Details

Accession Number:
0001193125-21-043666
Form Type:
13G Filing
Publication Date:
2021-02-16 09:16:51
Filed By:
Sb Investment Advisers (uk) Ltd
Company:
Relay Therapeutics Inc. (NASDAQ:RLAY)
Filing Date:
2021-02-16
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
SVF Pauling (Cayman) Limited 0 27,904,963 0 27,904,963 27,904,963 31.0%
SoftBank Vision Fund (AIV M 0 27,904,963 0 27,904,963 27,904,963 31.0%
SB Investment Advisers (UK) Limited 0 27,904,963 0 27,904,963 27,904,963 31.0%
Filing

 

 

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant

to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

Pursuant to § 240.13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.     )*

 

 

Relay Therapeutics, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

75943R102

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 75943R102    Schedule 13G    Page 1 of 8

 

  1    

  Names of Reporting Persons

 

  SVF Pauling (Cayman) Limited

  2  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  Cayman Islands

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5     

  Sole Voting Power

 

  0

   6   

  Shared Voting Power

 

  27,904,963

   7   

  Sole Dispositive Power

 

  0

   8   

  Shared Dispositive Power

 

  27,904,963

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  27,904,963

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  31.0%

12  

  Type of Reporting Person

 

  CO


CUSIP No. 75943R102    Schedule 13G    Page 2 of 8

 

  1    

  Names of Reporting Persons

 

  SoftBank Vision Fund (AIV M2) L.P.

  2  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5     

  Sole Voting Power

 

  0

   6   

  Shared Voting Power

 

  27,904,963

   7   

  Sole Dispositive Power

 

  0

   8   

  Shared Dispositive Power

 

  27,904,963

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  27,904,963

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  31.0%

12  

  Type of Reporting Person

 

  PN


CUSIP No. 75943R102    Schedule 13G    Page 3 of 8

 

  1    

  Names of Reporting Persons

 

  SB Investment Advisers (UK) Limited

  2  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  England and Wales

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5     

  Sole Voting Power

 

  0

   6   

  Shared Voting Power

 

  27,904,963

   7   

  Sole Dispositive Power

 

  0

   8   

  Shared Dispositive Power

 

  27,904,963

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  27,904,963

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  31.0%

12  

  Type of Reporting Person

 

  FI


CUSIP No. 75943R102    Schedule 13G    Page 4 of 8

 

ITEM 1.  (a)

Name of Issuer:

Relay Therapeutics, Inc. (the Issuer)

 

  (b)

Address of Issuers Principal Executive Offices:

399 Binney Street, 2nd Floor

Cambridge, MA 02139

 

ITEM 2.  (a)

Name of Person Filing:

Each of the following is hereinafter individually referred to as a Reporting Person and collectively as the Reporting Persons. This statement is filed on behalf of:

SVF Pauling (Cayman) Limited (SVF Pauling)

SoftBank Vision Fund (AIV M2) L.P. (AIV M2)

SB Investment Advisers (UK) Limited (SBIA UK)

 

  (b)

Address or Principal Business Office:

The address for SVF Pauling is c/o Walkers Corp Ltd., 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands. The address for AIV M2 is 251 Little Falls Drive, Wilmington, DE 19808. The address for SBIA UK is 69 Grosvenor Street, London W1K 3JP, United Kingdom.

 

  (c)

Citizenship of each Reporting Person is:

SVF Pauling is organized under the laws of the Cayman Islands. AIV M2 is organized under the laws of Delaware. SBIA UK is organized under the laws of England and Wales.

 

  (d)

Title of Class of Securities:

Common stock, par value $ 0.001 per share (Common Stock).

 

  (e)

CUSIP Number:

75943R102

 

ITEM 3.

Not applicable.


CUSIP No. 75943R102    Schedule 13G    Page 5 of 8

 

ITEM 4.  Ownership.

(a-c)

The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of November 10, 2020, based upon 89,984,775 shares of Common Stock outstanding.

 

Reporting Person   

Amount

beneficially

owned

  

Percent

of class:

  Sole
power
to vote
or to
direct
the vote:
   Shared
power to
vote or to
direct the
vote:
  

Sole
power to
dispose or
to direct
the
disposition

of:

  

Shared

power to

dispose or

to direct

the

disposition

of:

SVF Pauling (Cayman) Limited

   27,904,963    31.0%   0    27,904,963    0    27,904,963

SoftBank Vision Fund (AIV M2) L.P.

   27,904,963    31.0%   0    27,904,963    0    27,904,963

SB Investment Advisers (UK) Limited

   27,904,963    31.0%   0    27,904,963    0    27,904,963

SVF Pauling is the record holder of the shares of Common Stock reported herein.

SVF Pauling is a wholly owned subsidiary of AIV M2. SBIA UK has been appointed as alternative investment fund manager (AIFM) and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of AIV M2s investments.

 

ITEM 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

 

ITEM 6.

Ownership of More Than Five Percent on Behalf of Another Person.

Not applicable.

 

ITEM 7.

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

 

ITEM 8.

Identification and Classification of Members of the Group.

Not applicable.

 

ITEM 9.

Notice of Dissolution of Group.

Not applicable.


CUSIP No. 75943R102    Schedule 13G    Page 6 of 8

 

ITEM 10.

Certification.

Not applicable.


CUSIP No. 75943R102    Schedule 13G    Page 7 of 8

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 16, 2021

 

SVF Pauling (Cayman) Limited
By:  

/s/ Karen Ellerbe

Name:   Karen Ellerbe
Title:   Director
SoftBank Vision Fund (AIV M2) L.P.
By:   SB Investment Advisers (UK) Limited, its Manager
By:  

/s/ Brian Wheeler

Name:   Brian Wheeler
Title:   General Counsel
SB Investment Advisers (UK) Limited
By:  

/s/ Brian Wheeler

Name:   Brian Wheeler
Title:   General Counsel

CUSIP No. 75943R102    Schedule 13G    Page 8 of 8

 

LIST OF EXHIBITS

 

Exhibit No.

  

Description

99    Joint Filing Agreement.